249 related articles for article (PubMed ID: 31980336)
21. A novel mouse model of Graves' disease: implications for a role of aberrant MHC class II expression in its pathogenesis.
Shimojo N; Arima T; Yamaguchi K; Kikuoka S; Kohn LD; Kohno Y
Int Rev Immunol; 2000; 19(6):619-31. PubMed ID: 11129118
[TBL] [Abstract][Full Text] [Related]
22. Evidence that factors other than particular thyrotropin receptor T cell epitopes contribute to the development of hyperthyroidism in murine Graves' disease.
Pichurin PN; Chen CR; Nagayama Y; Pichurina O; Rapoport B; McLachlan SM
Clin Exp Immunol; 2004 Mar; 135(3):391-7. PubMed ID: 15008970
[TBL] [Abstract][Full Text] [Related]
23. Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves' Disease.
Inaba H; De Groot LJ; Akamizu T
Front Endocrinol (Lausanne); 2016; 7():120. PubMed ID: 27602020
[TBL] [Abstract][Full Text] [Related]
24. Activation of T lymphocyte subsets by synthetic TSH receptor peptides and recombinant glutamate decarboxylase in autoimmune thyroid disease and insulin-dependent diabetes.
Mukuta T; Yoshikawa N; Arreaza G; Resetkova E; Leushner J; Song YH; Akasu F; Onaya T; Volpé R
J Clin Endocrinol Metab; 1995 Apr; 80(4):1264-72. PubMed ID: 7714099
[TBL] [Abstract][Full Text] [Related]
25. Cathepsin S is not crucial to TSHR processing and presentation in a murine model of Graves' disease.
Kala M; Chen CR; McLachlan SM; Rapoport B; Aliesky H; Chapman HA
Immunology; 2005 Dec; 116(4):532-40. PubMed ID: 16313367
[TBL] [Abstract][Full Text] [Related]
26. Insight into Graves' hyperthyroidism from animal models.
McLachlan SM; Nagayama Y; Rapoport B
Endocr Rev; 2005 Oct; 26(6):800-32. PubMed ID: 15827111
[TBL] [Abstract][Full Text] [Related]
27. Graves' hyperthyroidism and thyroiditis in HLA-DRB1*0301 (DR3) transgenic mice after immunization with thyrotropin receptor DNA.
Flynn JC; Rao PV; Gora M; Alsharabi G; Wei W; Giraldo AA; David CS; Banga JP; Kong YM
Clin Exp Immunol; 2004 Jan; 135(1):35-40. PubMed ID: 14678262
[TBL] [Abstract][Full Text] [Related]
28. The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain.
Kikuoka S; Shimojo N; Yamaguchi KI; Watanabe Y; Hoshioka A; Hirai A; Saito Y; Tahara K; Kohn LD; Maruyama N; Kohno Y; Niimi H
Endocrinology; 1998 Apr; 139(4):1891-8. PubMed ID: 9528975
[TBL] [Abstract][Full Text] [Related]
29. Interferon-gamma ELISPOT detecting reactivity of T cells to TSH receptor peptides in Graves' disease.
Côté-Bigras S; Dionne A; Asselin-Mullen P; Leblicq C; Rottembourg D
Clin Endocrinol (Oxf); 2014 Feb; 80(2):296-300. PubMed ID: 23734883
[TBL] [Abstract][Full Text] [Related]
30. Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.
Schlüter A; Horstmann M; Diaz-Cano S; Plöhn S; Stähr K; Mattheis S; Oeverhaus M; Lang S; Flögel U; Berchner-Pfannschmidt U; Eckstein A; Banga JP
Clin Exp Immunol; 2018 Mar; 191(3):255-267. PubMed ID: 29058307
[TBL] [Abstract][Full Text] [Related]
31. A transgenic mouse that spontaneously develops pathogenic TSH receptor antibodies will facilitate study of antigen-specific immunotherapy for human Graves' disease.
McLachlan SM; Rapoport B
Endocrine; 2019 Nov; 66(2):137-148. PubMed ID: 31560118
[TBL] [Abstract][Full Text] [Related]
32. Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease.
Rapoport B; Aliesky HA; Chen CR; McLachlan SM
J Clin Endocrinol Metab; 2015 Jun; 100(6):E871-5. PubMed ID: 25856215
[TBL] [Abstract][Full Text] [Related]
33. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor.
Tahara K; Ishikawa N; Yamamoto K; Hirai A; Ito K; Tamura Y; Yoshida S; Saito Y; Kohn LD
Thyroid; 1997 Dec; 7(6):867-77. PubMed ID: 9459630
[TBL] [Abstract][Full Text] [Related]
34. Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades.
Morshed SA; Ando T; Latif R; Davies TF
Endocrinology; 2010 Nov; 151(11):5537-49. PubMed ID: 20844004
[TBL] [Abstract][Full Text] [Related]
35. A Mouse Thyrotropin Receptor A-Subunit Transgene Expressed in Thyroiditis-Prone Mice May Provide Insight into Why Graves' Disease Only Occurs in Humans.
McLachlan SM; Aliesky HA; Rapoport B
Thyroid; 2019 Aug; 29(8):1138-1146. PubMed ID: 31184281
[No Abstract] [Full Text] [Related]
36. Peptide scanning for thyrotropin receptor T-cell epitopes in mice vaccinated with naked DNA.
Pichurin P; Schwarz-Lauer L; Braley-Mullen H; Paras C; Pichurina O; Morris JC; Rapoport B; McLachlan SM
Thyroid; 2002 Sep; 12(9):755-64. PubMed ID: 12481940
[TBL] [Abstract][Full Text] [Related]
37. [The role of hereditary and environmental factors in autoimmune thyroid diseases].
Balázs C
Orv Hetil; 2012 Jul; 153(26):1013-22. PubMed ID: 22735372
[TBL] [Abstract][Full Text] [Related]
38. Critical Differences between Induced and Spontaneous Mouse Models of Graves' Disease with Implications for Antigen-Specific Immunotherapy in Humans.
Rapoport B; Banuelos B; Aliesky HA; Hartwig Trier N; McLachlan SM
J Immunol; 2016 Dec; 197(12):4560-4568. PubMed ID: 27913646
[TBL] [Abstract][Full Text] [Related]
39. TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.
Nagayama Y; Saitoh O; McLachlan SM; Rapoport B; Kano H; Kumazawa Y
Clin Exp Immunol; 2004 Dec; 138(3):417-22. PubMed ID: 15544617
[TBL] [Abstract][Full Text] [Related]
40. Proliferative responses of peripheral blood mononuclear cells from patients with Graves' disease to synthetic peptides epitopes of human thyrotropin receptor.
Okamoto Y; Yanagawa T; Fisfalen ME; DeGroot LJ
Thyroid; 1994; 4(1):37-42. PubMed ID: 7519915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
